Those who applied for < KNN(058400) > hit the daily limit up in just one day! Achieved 33%!
Congratulations to everyone who signed up for the free trial. ^^
※ It's okay if you applied late, we will run it again.
※ Finally starting. KNN(058400) follow-up stock hits the daily limit up on Tuesday. ※
The government has approved the import of COVID-19 ‘Remdesivir’!
Expanding from the U.S. to Europe!!
▶▶ Heading straight ‘UP’ on Tuesday. The best beneficiary stock among them! Don’t miss it
[Apply now for Remdesivir-related stocks]
“I was really surprised to see it hit the daily limit up in just one day after applying. I wondered if this was real. Then I kept receiving it during the free trial period and it was a continuous limit up march. Truly amazing. Now I pay the membership fee and do it officially, and the fee is not a waste at all because it makes me earn more every day. I am really happy. Thank you.”
(VIP Self-employed Jeon Jeong-pyo, 53 years old member)
Think this is your last chance. You must seize the opportunity when it comes.
It will explode exactly on “June 2”! Don’t miss it and regret it, buy even with just 1 million KRW!
▶▶ “June 2 Daily Limit Up” offered only until today and then closed. [Get it now!] ▶ Get the stock ◀
[AI recent daily limit up hits]
*20.05.29 KNN (058400) Limit Up hit!
*20.05.28 Namyoung Vivian (002070) Limit Up hit!
*20.05.27 T-PLEX (081150) Limit Up hit!
*20.05.26 Koryo Pharmaceutical (014570) Limit Up hit!
*20.05.22 SecuCube (131090) Limit Up hit!
*20.05.22 Union Materials (215100) Limit Up hit!
*20.05.20 RoboRobo (215100) Limit Up hit!
*20.05.20 Antrogen (065660) Limit Up hit!
*20.05.19 ABProBio (195990) Limit Up hit!
*20.05.19 Powernet (037030) Limit Up hit!
*20.05.18 SK Bioland (052260) Limit Up hit!
*20.05.08 Esmo Materials (087730) 2 consecutive Limit Up hits!
▶▶ Only for exactly 30 people. “Tuesday Daily Limit Up”! ▶ Get it now ◀
※ First-come, first-served 30 people limit! The last ‘buzzer beater’ before the 4th quarter ends is recruiting. ※
[Today's stocks of interest]
#Pharmicell #Bioneer #GeneOneLifeScience #AccessBio #AprogenPharmaceutical
※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

